Tanzania Agency Bans Heartburn Medications Over 'Cancer Risk'

The Tanzania Medicines and Medical Devices Authority has said that the drugs, with the trade names Raniplex 150 mg, Rantac 500 mg/mL and Aciloc 150 mg, which were registered for use in Tanzania contain an impurity that can cause cancer. The authorities have asked all patients taking heartburn drugs with the active ingredient ranitidine to stop their course of treatment and report to a nearby health facility.

(file photo).

Don't Miss

AllAfrica publishes around 800 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.